Ketogenic Diet As a Therapeutic Approach in Autism Spectrum Disorder: a Narrative Review

Overview

Journal Metab Brain Dis

Publisher Springer

Specialties Endocrinology
Neurology

Date 2024 Dec 18

PMID 39692905

Authors

Elif Ozturk

Nazli Nur Aslan Cin

Ali Cansu

Asli Akyol

Affiliations

Soon will be listed here.

Abstract

The ketogenic diet (KD) originated in the 1920s. It is a dietary model that is low in carbohydrates, adequate in protein, and high in fat content. The diet mimics starvation and increases the production of ketone bodies, leading to ketosis in metabolism. KD is used as an anticonvulsant treatment approach in patients with drug-resistant epilepsy. In addition, it is thought that a KD may have therapeutic potential in the treatment of neurological disorders, including autism spectrum disorders (ASD). Numerous recent studies have demonstrated that a KD can improve behavioural parameters in individuals with ASD. This review aims to address the potential mechanisms of action of the KD and to examine the effects of the KD on individuals diagnosed with ASD. It is likely that this role is mediated through improvements in energy metabolism, reduction of pro-inflammatory cytokine levels, control of neurotransmitters, gene expression and modulation of the gut microbiota. Based on the available evidence, a KD appears to be a safe and effective treatment for ASD.

References

Ahmad S, Ansari M, Nadeem A, Bakheet S, Al-Ayadhi L, Attia S . Elevated IL-16 expression is associated with development of immune dysfunction in children with autism. Psychopharmacology (Berl). 2018; 236(2):831-838. DOI: 10.1007/s00213-018-5120-4. View

Ahmad S, Al Thobiti T, El Toum M, Al Harbi F . Florid Scurvy in an Autistic Child on a Ketogenic Diet. Pediatr Emerg Care. 2018; 37(8):e483-e484. DOI: 10.1097/PEC.0000000000001695. View

Ahmed S, Elhefnawy A, Azouz H, Roshdy Y, Ashry M, Ibrahim A . Study of the gut Microbiome Profile in Children with Autism Spectrum Disorder: a Single Tertiary Hospital Experience. J Mol Neurosci. 2020; 70(6):887-896. DOI: 10.1007/s12031-020-01500-3. View

Albers J, Kraja G, Eller D, Eck K, McBrian D, Bain J . Assessing the feasibility of using the ketogenic diet in autism spectrum disorder. J Hum Nutr Diet. 2022; 36(4):1303-1315. DOI: 10.1111/jhn.13115. View

Ashtary-Larky D, Bagheri R, Bavi H, Baker J, Moro T, Mancin L . Ketogenic diets, physical activity and body composition: a review. Br J Nutr. 2021; 127(12):1898-1920. PMC: 9244428. DOI: 10.1017/S0007114521002609. View

Bertuccioli A, Cardinali M, DI Pierro F, Zonzini G, Matera M . Ketogenic and Low FODMAP Diet in Therapeutic Management of a Young Autistic Patient with Epilepsy and Dysmetabolism Poorly Responsive to Therapies: Clinical Response and Effects of Intestinal Microbiota. Int J Mol Sci. 2022; 23(15). PMC: 9368964. DOI: 10.3390/ijms23158829. View

Bjorklund G, Waly M, Al-Farsi Y, Saad K, Dadar M, Rahman M . The Role of Vitamins in Autism Spectrum Disorder: What Do We Know?. J Mol Neurosci. 2019; 67(3):373-387. DOI: 10.1007/s12031-018-1237-5. View

Boison D . New insights into the mechanisms of the ketogenic diet. Curr Opin Neurol. 2017; 30(2):187-192. PMC: 5409832. DOI: 10.1097/WCO.0000000000000432. View

Boison D, Masino S, Geiger J . Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy. Expert Opin Drug Discov. 2011; 6(7):713-724. PMC: 3124847. DOI: 10.1517/17460441.2011.575777. View

10.

Borea P, Gessi S, Merighi S, Vincenzi F, Varani K . Pharmacology of Adenosine Receptors: The State of the Art. Physiol Rev. 2018; 98(3):1591-1625. DOI: 10.1152/physrev.00049.2017. View

11.

Bostock E, Kirkby K, Taylor B . The Current Status of the Ketogenic Diet in Psychiatry. Front Psychiatry. 2017; 8:43. PMC: 5357645. DOI: 10.3389/fpsyt.2017.00043. View

11.

Calderon N, Betancourt L, Hernandez L, Rada P . A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study. Neurosci Lett. 2017; 642:158-162. DOI: 10.1016/j.neulet.2017.02.014. View

12.

DeCampo D, Kossoff E . Ketogenic dietary therapies for epilepsy and beyond. Curr Opin Clin Nutr Metab Care. 2019; 22(4):264-268. DOI: 10.1097/MCO.0000000000000565. View

12.

Bough K, Wetherington J, Hassel B, Pare J, Gawryluk J, Greene J . Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol. 2006; 60(2):223-35. DOI: 10.1002/ana.20899. View

13.

Evangeliou A, Vlachonikolis I, Mihailidou H, Spilioti M, Skarpalezou A, Makaronas N . Application of a ketogenic diet in children with autistic behavior: pilot study. J Child Neurol. 2003; 18(2):113-8. DOI: 10.1177/08830738030180020501. View

14.

Fu S, Li S, Wang J, Li Y, Xie S, Xue W . BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-κB activation. Mediators Inflamm. 2014; 2014:983401. PMC: 3997897. DOI: 10.1155/2014/983401. View

14.

Chen F, He X, Luan G, Li T . Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities. Front Neurol. 2019; 10:119. PMC: 6399128. DOI: 10.3389/fneur.2019.00119. View

15.

De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti D . Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013; 8(10):e76993. PMC: 3793965. DOI: 10.1371/journal.pone.0076993. View

15.

Gano L, Patel M, Rho J . Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res. 2014; 55(11):2211-28. PMC: 4617125. DOI: 10.1194/jlr.R048975. View

16.

Gzielo K, Soltys Z, Rajfur Z, Setkowicz Z . The Impact of the Ketogenic Diet on Glial Cells Morphology. A Quantitative Morphological Analysis. Neuroscience. 2019; 413:239-251. DOI: 10.1016/j.neuroscience.2019.06.009. View